DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dutasteride And Tamsulosin Hydrochloride, and what generic alternatives are available?
Dutasteride And Tamsulosin Hydrochloride is a drug marketed by Actavis Labs Fl Inc, Aurobindo Pharma, Endo Operations, and Zydus Pharms. and is included in four NDAs.
The generic ingredient in DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dutasteride And Tamsulosin Hydrochloride
A generic version of DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE was approved as dutasteride; tamsulosin hydrochloride by ENDO OPERATIONS on February 26th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
- What are the global sales for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
- What is Average Wholesale Price for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE?
Summary for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 5 |
| Clinical Trials: | 21 |
| DailyMed Link: | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Beth Israel Deaconess Medical Center | N/A |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Ministry of Health, France | Phase 3 |
See all DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE clinical trials
Pharmacology for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
| Drug Class | 5-alpha Reductase Inhibitor alpha-Adrenergic Blocker |
| Mechanism of Action | 5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists |
US Patents and Regulatory Information for DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 202975-001 | Nov 20, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 207769-001 | May 24, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 213300-001 | Jul 18, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
